uniQure Provides Positive Recommendation to Advance P- I/II Study of AMT-130 for Huntington Disease
Shots: The DSMB recommended continued the dosing in the P- I/II clinical trial assessing AMT-130 in patients with a second higher-dose cohort, after review safety […]